Quanterix (QTRX) Reports Q3 Revenues Beat

Quanterix (NASDAQ: QTRX) reported Q3 revenue for the quarter came in at $14.94 million versus the consensus estimate of $12.62 million.

“We are pleased with our execution and yet another record quarter with strong revenue growth, successful early launch of our new HD-X Analyzer and material progress accelerating global adoption of our ultra-sensitive Simoa technology,” said Kevin Hrusovsky, Chief Executive Officer, President and Chairman, Quanterix. “We are excited to have accelerated the HD-X Analyzer shipments a quarter early and also to have strengthened our balance sheet with a successful follow-on offering. We believe our growth trajectory and financial performance speak for themselves. We remain confident in our impressive opportunity for value creation as we pioneer disruption in healthcare. Our next major opportunity to advance our commercial momentum is by participating in the upcoming Powering Precision Health Summit in Barcelona, Spain, on November 19, 2019, where over 40 top researchers are lined up to present on the disruptive potential of biomarker technology to transform drug development and enable a sea change advance in precision health.”

For earnings history and earnings-related data on Quanterix (QTRX) click here.

You May Also Be Interested In

• Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
• Hilton (HLT) Tops Q1 EPS by 11c, Beats on Revenue; Offers FY24 EPS Guidance
• Group 1 Automotive (GPI) Tops Q1 EPS by 9c